ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-OR13

Channel Function of Polycystin-2 in Endoplasmic Reticulum Protects Against Polycystic Kidney Disease

Session Information

Category: Genetic Diseases of the Kidneys

  • 1101 Genetic Diseases of the Kidneys: Cystic

Authors

  • Padhy, Biswajit, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Xie, Jian, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Wang, Runping, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Lin, Fang, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
  • Huang, Chou-Long, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States

Group or Team Name

  • Huang Lab
Background

Autosomal dominant polycystic kidney disease (ADPKD) is among the most common monogenic inherited disease in humans leading to end-stage renal disease. Mutations in PKD2 gene that encodes PC2 protein are responsible for ~15% of the ADPKD cases. The prevailing view is that altered Ca2+ influx by mutated PC2 in the primary cilia is the cause for ADPKD pathogenesis. Yet, most of PC2 is localized to endoplasmic reticulum (ER) and more permeable to K+ than Ca2+. In the cilia-centric view, ER-localized PC2 mainly facilitates ciliary targeting of PC1-PC2 complexes.

Methods

The trimeric intracellular channel-B (TricB), aka TMEM38B, is an ER resident K+ channel that mediates K+-Ca2+ counterion exchange for inositol trisphosphate-mediated Ca2+ release. Using TricB as experimental tool, we explored the function of ER-localized PC2 and its role in ADPKD pathogenesis by using cultured cells, zebrafish, and mouse models.

Results

ATP-induced ER Ca2+ release was defective in PC2-null renal epithelial cells, which was reversed by exogenous expression of TricB. Likewise, exogenous PC2 reversed ER Ca2+ release defect in TricB-null HEK293 cells. Microinjection of wildtype but not non-functional TricB mRNA into PC2-morphant zebrafish embryos ameliorated pronephric cysts. Similarly, ER targeting of ROMK K+ channel normally expresses on the plasma membrane suppressed the cystic phenotypes. R6G mutant of PC2 that fails to localize to cilia was still capable of reversing ER Ca2+ release defect in PC2-null cultured cells and PC2-deficient zebrafish phenotypes. Transgenic expression of TricB reversed cystic phenotypes in conditional Pkd2-inactivated mice. TricB deletion enhanced cystogenesis in Pkd2-heterozygous kidneys.

Conclusion

ER-localized PC2 plays an important role in the pathogenesis of ADPKD. It acts as a K+ channel to facilitate K+-Ca2+ counterion exchange for inositol trisphosphate-mediated Ca2+ release. The results challenge the current cilia-centric dogma providing insights for understanding ADPKD pathogenesis and proof-of-principle for pharmacotherapy by TricB activators.

Funding

  • NIDDK Support